TTK Healthcare ‘s Q2 Financial results: Revenue Grows by 6.85% YoY

The comprehensive analytics outlining the performance and outlook of TTK Healthcare Limited‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at TTK Healthcare Limited’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 6.85 %. However, it did see a marginal slip of -4.53 % from the previous quarter. Expenses decreased slightly by -5.34 % quarter-on-quarter, aligning with the annual rise of 7.96 %. Operating profit, while down -13.73 % compared to last year, faced a quarter-on-quarter increase of 19.1 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.99 %, but an expansion of 0.83 % sequentially. Other income fell by -51.89 % compared to the last quarter, despite an annual growth of 10.44 %. Interest expenses dropped significantly by -13.95 % from the previous quarter, yet the year-over-year increase remains at a moderate 1.37 %. Depreciation costs fell by -1.95 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -38.72 %. Profit before tax grew annually by 7.51 % but saw a reduction from the preceding quarter by -43.19 %.
Tax expenses as a percentage of profits increased slightly by 0.08 % compared to last year, with a more notable quarter-on-quarter increase of 3.22 %. Net profit rose by 7.43 % year-on-year but witnessed a -45.54 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 7.41 % but a quarterly fall of -45.55 %. In summary, TTK Healthcare Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing TTK Healthcare Limited’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 6.85 % year-on-year growth, although there was a slight dip of -4.53 % from the previous quarter. Expenses rose by 7.96 % compared to the previous year, with a decrease of -5.34 % quarter-on-quarter. Operating Profit dropped by -13.73 % annually, and saw a 19.1 % increase from the last quarter.
Net Profit showed yearly increase of 7.43 %, and experienced a -45.54 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 7.41 % annually, however dipped by -45.55 % compared to the last quarter. In essence, while TTK Healthcare Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.